The FDA is curiously not one of the HHS entities coordinating the US response to the outbreak, but must monitor for manufacturing disruptions and shortages, as well as approve new treatments and diagnostics.
US FDA Commissioner Stephen Hahn speaks during an HHS briefing about coronavirus on 7 February 2020. He was called up from the audience to address manufacturing issues since FDA is not part of the administration's task force charged with responding to the outbreak. • Source: Screenshot of HHS webcast
